Changing Times at the OST

Sir Robert May, outgoing UK Chief Scientist, spoke to Robert Walgate about treading the fine line between government and the science community, and the changing face of science in the UK and Europe.

Written byRobert Walgate
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Sir Robert May, outgoing UK Chief Scientist, spoke to Robert Walgate about treading the fine line between government and the science community, and the changing face of science in the UK and Europe.

As UK Chief Scientist and Head of the Office of Science and Technology [OST] aren't you in an ambiguous position? Both regulator and champion of science and technology?

"I don't think the OST is either. We are a source of independent advice. Which is why the head of the Office is an outsider. I see my own responsibility as walking a quite interesting line. I'm a civil servant whose whole purpose is to challenge. Really looking at things, right across all of science and engineering, medicine and social science; and to make sure that it is being handled well, that decisions are being made openly and taking account of all viewpoints. And to intervene in the rare ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies